Found: 16
Select item for more details and to access through your institution.
Nimustine Treatment of 11 Cases of Canine Histiocytic Sarcoma.
- Published in:
- Journal of the American Animal Hospital Association, 2020, v. 56, n. 3, p. 146, doi. 10.5326/JAAHA-MS-6959
- By:
- Publication type:
- Article
A feline case of multiple myeloma treated with bortezomib.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Molecular changes associated with the development of resistance to imatinib in an imatinib-sensitive canine neoplastic mast cell line carrying a KIT c.1523A>T mutation.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 6, p. 524, doi. 10.1111/ejh.12526
- By:
- Publication type:
- Article
Immunophenotyping and gene rearrangement analysis in dogs with lymphoproliferative disorders characterized by small-cell lymphocytosis.
- Published in:
- Journal of Veterinary Diagnostic Investigation, 2009, v. 21, n. 2, p. 197, doi. 10.1177/104063870902100203
- By:
- Publication type:
- Article
Big Insulin-like Growth Factor 2–Producing Tumor in a Hypoglycemic Dog.
- Published in:
- Veterinary Pathology, 2020, v. 57, n. 3, p. 432, doi. 10.1177/0300985820906897
- By:
- Publication type:
- Article
A canine case of malignant melanoma carrying a KIT c.1725_1733del mutation treated with toceranib: a case report and in vitro analysis.
- Published in:
- BMC Veterinary Research, 2021, v. 17, n. 1, p. 1, doi. 10.1186/s12917-021-02864-3
- By:
- Publication type:
- Article
DC-HIL<sup>+</sup> CD14<sup>+</sup> HLA-DR<sup>no/low</sup> Cells Are a Potential Blood Marker and Therapeutic Target for Melanoma.
- Published in:
- Journal of Investigative Dermatology, 2014, v. 134, n. 11, p. 2839, doi. 10.1038/jid.2014.248
- By:
- Publication type:
- Article
DC-HIL-Expressing Myelomonocytic Cells Are Critical Promoters of Melanoma Growth.
- Published in:
- Journal of Investigative Dermatology, 2014, v. 134, n. 11, p. 2784, doi. 10.1038/jid.2014.254
- By:
- Publication type:
- Article
Molecular Characterization of the Cytidine Monophosphate-N-Acetylneuraminic Acid Hydroxylase (CMAH) Gene Associated with the Feline AB Blood Group System.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0165000
- By:
- Publication type:
- Article
The DC- HIL ligand syndecan-4 is a negative regulator of T-cell allo-reactivity responsible for graft-versus-host disease.
- Published in:
- Immunology, 2013, v. 138, n. 2, p. 173, doi. 10.1111/imm.12027
- By:
- Publication type:
- Article
Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours.
- Published in:
- British Journal of Haematology, 2010, v. 148, n. 1, p. 144, doi. 10.1111/j.1365-2141.2009.07926.x
- By:
- Publication type:
- Article
Establishment of a BRAF V595E‐mutant canine prostate cancer cell line and the antitumor effects of MEK inhibitors against canine prostate cancer.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 221, doi. 10.1111/vco.12879
- By:
- Publication type:
- Article
Molecular characterization of canine SHP2 mutants and anti‐tumour effect of SHP2 inhibitor, SHP099, in a xenograft mouse model of canine histiocytic sarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 109, doi. 10.1111/vco.12751
- By:
- Publication type:
- Article
Canine histiocytic sarcoma cell lines with SHP2 p.Glu76Gln or p.Glu76Ala mutations are sensitive to allosteric SHP2 inhibitor SHP099.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 2, p. 161, doi. 10.1111/vco.12524
- By:
- Publication type:
- Article
Genetic alterations of KIT during clonal expansion and subsequent acquisition of resistance to toceranib in a canine mast cell tumor cell line.
- Published in:
- Journal of Veterinary Pharmacology & Therapeutics, 2019, v. 42, n. 6, p. 673, doi. 10.1111/jvp.12816
- By:
- Publication type:
- Article
A decrease in ubiquitination and resulting prolonged life-span of KIT underlies the KIT overexpression-mediated imatinib resistance of KIT mutation-driven canine mast cell tumor cells.
- Published in:
- Oncology Reports, 2017, v. 38, n. 4, p. 2543, doi. 10.3892/or.2017.5865
- By:
- Publication type:
- Article